Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) today announced that it has entered into a committed equity financing facility under which it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE